Tautomer is a South African based specialist technology company that offers a ground-breaking treatment option for patients with non-melanoma skin cancer (NMSC). The technology known as Rhenium-SCT® utilizes the Beta emitter radioisotope Rhenium-188 to painlessly treat NMSC without the need for invasive surgery, therefore providing positive aesthetic outcomes. The Rhenium 188 Low Dose treatment utilised the same technology to treat Keloids.

Tautomer is committed to changing the way people think about NMSC and Keloid treatment, leading the field in innovation, and improving patients’ quality of life.